Provider group hails delay of labor board's notice posting requirement

Share this article:
A senior living group welcomed a decision by a U.S. appeals court to grant an injunction blocking implementation of the National Labor Relations Board's notice posting rule.

Scheduled to go into effect April 30, the contentious NLRB rule would have required employers to display posters informing workers of their right to unionize. But two groups, the National Association of Manufacturers and the Coalition for a Democratic Workplace, asked the U.S. Court of Appeals for the District of Columbia Circuit for an injunction after a federal district judge dismissed the case a month ago. An appeal of this decision is pending.

The Assisted Living Federation of America, which has been vociferous in its opposition to this rule, praised the decision, saying that the NLRB lacks the authority to enforce the requirement.

“The posting requirement rule is a one-sided initiative that would have prevented employees from making informed decisions about all of their rights under the National Labor Relations Act,” ALFA President and CEO Richard Grimes said in a statement. 

The injunction follows a similar decision last week by U.S. District Judge David Norton, who ruled that the NLRB exceeded its authority in issuing the requirement.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.